In this issue:
Hyperfractionation vs. standard fractionation for locally advanced recurrent nasopharyngeal carcinoma
HPV status & suicide risk in head & neck cancer
OS, tumour characteristics & treatment strategies in anaplastic thyroid cancer
Surgical margin distance & survival in resected HNSCC
Pembrolizumab monotherapy in advanced thyroid cancer
PPIs & antibiotics impede efficacy of nivolumab in recurrent/metastatic HNSCC
Xevinapant + chemoradiotherapy in high-risk locally advanced HNSCC
Surgical site complications following isolated salvage vs. primary neck dissection
Biomarkers of response to pembrolizumab in head & neck cancer
A nomogram for adjuvant/maintenance chemotherapy after induction chemotherapy & concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma
Please login below to download this issue (PDF)